By Gerald L. Maatman, Jr. and Jennifer A. Riley
Duane Morris Takeaway: The healthcare industry continues to face a rapidly evolving class action landscape, and 2025 has proven to be a pivotal year. For that reason, we are pleased to announce the publication of our latest industry-focused eBook, the Healthcare Class Action Review – 2026. From data privacy disputes to billing transparency and pharmaceutical liability, class action litigation is reshaping how healthcare organizations operate and manage risk.
The Healthcare Class Action Review – 2026 is a comprehensive new eBook that examines the most significant developments in healthcare-related class actions over the past year. Healthcare organizations today operate at the intersection of regulation, innovation, and patient expectations. Class action litigation involving healthcare companies, including hospitals, healthcare providers, pharmaceutical companies, biotechnology firms, medical device and health technology companies, and diagnostic and testing companies has evolved from a peripheral phenomenon into a central feature of complex class action litigation. The Healthcare Class Action Review – 2026 offers a clear, structured analysis of these trends, helping legal professionals, compliance teams, and industry leaders stay informed and prepared.
As enforcement intensifies and plaintiffs’ strategies become more sophisticated, understanding class action risk is no longer optional—it’s essential. The Healthcare Class Action Review – 2026 equips readers with the knowledge needed to anticipate challenges and respond effectively in an increasingly complex legal environment.
Download your copy today and stay ahead of the curve in healthcare litigation.
Stay tuned to the Class Action Weekly Wire for more information on the Healthcare Class Action Review – 2026 coming soon!